SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 121,799.31 |
| Enterprise Value ($M) | 161,212.31 |
| Book Value ($M) | 17,200.00 |
| Book Value / Share | 8.48 |
| Price / Book | 7.08 |
| NCAV ($M) | -46,435.00 |
| NCAV / Share | -22.88 |
| Price / NCAV | -2.62 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.13 |
| Return on Assets (ROA) | -0.09 |
| Return on Equity (ROE) | -0.54 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.15 |
| Current Ratio | 1.25 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 29,780.00 |
| Assets | 92,603.00 |
| Liabilities | 76,215.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 48,300.00 |
| Operating Income | 9,705.00 |
| Net Income | -8,948.00 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 15,190.00 |
| Cash from Investing | -21,352.00 |
| Cash from Financing | 5,127.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,683,795 | 7,669,573 | 21.95 | |
| 1,814,796 | 8,737,408 | 20.77 | |
| 1,243,880 | 6,028,377 | 20.63 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ANVS – Annovis Bio, Inc. | BHC – Bausch Health Companies Inc. |
| BHVN – Biohaven Ltd. | EBS – Emergent BioSolutions Inc. |
| ELAN – Elanco Animal Health Incorporated |